John Walsh analyst

Currently out of the existing stock ratings of John Walsh, 96 are a HOLD (35.29%), 162 are a BUY (59.56%), 14 are a SELL (5.15%).

John Walsh

Work Performance Price Targets & Ratings Chart

Analyst John Walsh, currently employed carries an average stock price target met ratio of 64.52% that have a potential upside of 23.26% achieved within 237 days. Previously, John Walsh worked at CREDIT SUISSE.

John Walsh’s has documented 570 price targets and ratings displayed on 36 stocks. The coverage was on Industrials, Technology, Basic Materials, Healthcare sectors.

Most recent stock forecast was given on PNT, POINT Biopharma Global at 04-Oct-2023.

Wall Street Analyst John Walsh

Analyst best performing recommendations are on GTLS (CHART INDUSTRIES).
The best stock recommendation documented was for GTLS (CHART INDUSTRIES) at 10/13/2020. The price target of $80 was fulfilled within 1 day with a profit of $4.69 (6.23%) receiving and performance score of 62.28.

Average potential price target upside

ALLE Allegion PLC ANSS ANSYS AQUA Evoqua Water Technologies ATKR Atkore International Group AYI Acuity Brands CARR Carrier Global Corp EMR Emerson Electric Company ETN Eaton PLC FLS Flowserve FTV Fortive Corp GE General Electric Company GTLS Chart Industries HON Honeywell International IR Ingersoll Rand JCI Johnson Controls International PLC LII Lennox International MMM 3M Company MTTR Matterport OTIS Otis Worldwide Corp ROK Rockwell Automation TT Trane Technologies plc VNT Vontier Corp XYL Xylem DD Dupont De Nemours BGRY Berkshire Grey CRIS Curis CTSO Cytosorbents Crp FUSN Fusion Pharmaceuticals  HROW Harrow Health LNTH Lantheus Holdings SNDX Syndax Pharmaceuticals STRC Sarcos Technology and Robotics VOR Vor Biopharma VRAY ViewRay PNT POINT Biopharma Global THTX Theratechnologies .

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$137

$-6.78 (-4.72%)

$135

16 days ago
(28-Oct-2024)

16/21 (76.19%)

$-5.33 (-3.74%)

286

Hold

$152

$8.22 (5.72%)

$116

19 days ago
(25-Oct-2024)

13/14 (92.86%)

$9.4 (6.59%)

428

Hold

$150

$6.22 (4.33%)

$141

27 days ago
(17-Oct-2024)

8/9 (88.89%)

$-2.48 (-1.63%)

308

Hold

$100

$-43.78 (-30.45%)

$128

1 years 25 days ago
(19-Oct-2023)

2/2 (100%)

$2.56 (2.63%)

208

$127

$-16.78 (-11.67%)

$120

1 years 3 months 17 days ago
(27-Jul-2023)

23/23 (100%)

$13.29 (11.69%)

285

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by John Walsh?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?